DETERMINE TOXICITY AND ANTIBODY RESPONSES WITH A KLH CONJUGATED BIVALENT VACCINE CONTAINING GD2 LACTONE, GD3 LACTONE WITH IMMUNOLOGICAL ADJUVANT QS-DG OR OPT-821 IN PATIENTS WITH DISEASE FREE AJCC STAGE III OR IV CUTANEOUS MELANOMA: